ViaDerma Inc (VDRM)

[Rubyt]

I think the sales projections you show for 2017 are not correct. In the web interview, Otiko spoke about sales $'s at 500k to 1M for 2017. You have indicated sales units rather than sales $ in your analysis. At Otiko's sales projections the stock will have difficulty sustaining a PPS above .10 and it will be a long while before the company takes off. I am very long on this stock and willing to wait for the return that everyone is expecting.